Tarcic, Nora,Haviv, Asi,Blaugrund, Eran,Kaye, Joel
申请号：
AU2013214909
公开号：
AU2013214909A1
申请日:
2013.02.01
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
This application provides for a method of treating a human patient afflicted with anti-TNFa refractory Crohns disease, of treating a human patient afflicted with non-fibrostenotic Crohns disease, and of treating a human patient whose Crohns disease had not been surgically treated, the method comprising periodically administering to the patient an amount of laquinimod or pharmaceutically acceptable salt thereof effective to treat the patient. This application also provides for a method of inducing or maintaining clinical remission in a human patient afflicted with Crohns disease comprising periodically administering to the patient an amount of laquinimod effective to induce or maintain clinical remission in the patient, which amount of laquinimod is less than 0.5 mg/day.
